The WVU Rockefeller Neuroscience Institute (RNI) is providing patients greater statewide and regional access to a ...

The WVU Rockefeller Neuroscience Institute is providing patients greater statewide and regional access to a groundbreaking ...

New research suggests Alzheimer's drugs may improve cognition by increasing Aβ42 levels rather than just reducing plaques, ...

The U.S. Food and Drug Administration (FDA) recently granted accelerated approval of a treatment for adults with metastatic ...

One year earlier, in June 2021, the US Food and Drug Administration had approved aducanumab, an antibody-targeting beta-amyloid, as a treatment for Alzheimer's, even though the data supporting its use ...

In November 2020, an FDA advisory panel of experts voted against the approval of a monoclonal antibody called aducanumab. A major concern with aducanumab was the frequency of side-effects ...

In this issue of EMBO Molecular Medicine, Sun and colleagues report the development of a novel therapeutic approach, and preclinical proof-of-concept evidence of its efficacy, for Autosomal Dominant ...

In a clinical study, 16 radiologists read 199 retrospective MRI scans from the aducanumab Phase 2 and 3 trials either with or without the assistance of icobrain aria. The radiologists had an average ...

The Schmitts agreed to receive a monthly infusion of Aducanumab, which is based on the same principle as Leqembi: It is an antibody, in this case from the U.S. biotechnology company Biogen.